179 related articles for article (PubMed ID: 1691407)
21. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
Riegger GA
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
[TBL] [Abstract][Full Text] [Related]
22. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
[TBL] [Abstract][Full Text] [Related]
23. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the efficacy and safety of quinapril vs. captopril in treatment of moderate to severe hypertension.
Schnaper HW
Angiology; 1989 Apr; 40(4 Pt 2):389-95. PubMed ID: 2650582
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
26. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
Larochelle P; Haynes B; Maron N; Dugas S
Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
[TBL] [Abstract][Full Text] [Related]
27. Comparative pharmacokinetics of captopril, enalapril, and quinapril.
Vertes V; Haynie R
Am J Cardiol; 1992 Apr; 69(10):8C-16C. PubMed ID: 1546641
[TBL] [Abstract][Full Text] [Related]
28. The treatment of mild to moderate hypertension with ACE inhibitors.
Taylor SH
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S24-8. PubMed ID: 1691403
[TBL] [Abstract][Full Text] [Related]
29. Comparative trial of quinapril versus captopril in mild to moderate congestive heart failure. Quinapril/Captopril Congestive Heart Failure Study Group.
Gavazzi A; Marioni R; Campana C; Montemartini C
J Hypertens Suppl; 1994 Jul; 12(4):S89-93. PubMed ID: 7965279
[TBL] [Abstract][Full Text] [Related]
30. Assessing the clinical need for short-term conversion from oral to parenteral angiotensin converting enzyme inhibitor therapy in hypertensive patients. A quinapril to quinaprilat placebo-controlled model.
Whelton A; McCormick L; Wombolt D; Goldstein R; Canter D
Eur Heart J; 1997 Jan; 18(1):140-7. PubMed ID: 9049526
[TBL] [Abstract][Full Text] [Related]
31. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
Riegger GA
Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
[TBL] [Abstract][Full Text] [Related]
32. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
Yaoka O; Aoki K; Nakajima T; Setoguchi M
Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
[TBL] [Abstract][Full Text] [Related]
33. The incidence of first-dose hypotension with quinapril in patients with mild to moderate hypertension.
Maclean D; Maton SM; Bibby AJ; Eminton Z
Br J Clin Pract; 1993; 47(5):234-6. PubMed ID: 8292465
[TBL] [Abstract][Full Text] [Related]
34. Quinapril and hydrochlorothiazide combination for control of hypertension: assessment by factorial design. Quinapril Investigator Group.
Canter D; Frank GJ; Knapp LE; Phelps M; Quade M; Texter M
J Hum Hypertens; 1994 Mar; 8(3):155-62. PubMed ID: 8006914
[TBL] [Abstract][Full Text] [Related]
35. An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heart failure.
Beynon JH; Pathy MS
Curr Med Res Opin; 1997; 13(10):583-92. PubMed ID: 9327193
[TBL] [Abstract][Full Text] [Related]
36. Use of quinapril in the elderly patient.
Schnaper HW
Am J Hypertens; 1990 Nov; 3(11):278S-282S. PubMed ID: 2261146
[TBL] [Abstract][Full Text] [Related]
37. Quinapril: a double-blind, placebo-controlled trial in essential hypertension.
Maclean D
Angiology; 1989 Apr; 40(4 Pt 2):370-81. PubMed ID: 2650581
[TBL] [Abstract][Full Text] [Related]
38. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
[TBL] [Abstract][Full Text] [Related]
39. Overview of the clinical development of quinapril.
Frank GJ
Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
[TBL] [Abstract][Full Text] [Related]
40. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension: the Quinapril Titration Interval Management Evaluation (ATIME) Study. ATIME Research Group.
Flack JM; Yunis C; Preisser J; Holmes CB; Mensah G; McLean B; Saunders E
Arch Intern Med; 2000 Jun; 160(12):1842-7. PubMed ID: 10871979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
